BIONEXUS GENE LAB CORP (BGLC) Stock Overview
USA - NASDAQ:BGLC - US0906283066 - Common Stock
BGLC Key Statistics, Chart & Performance
The current stock price of BGLC is 5.77 USD. In the past month the price decreased by -1.88%. In the past year, price increased by 29.27%.
BGLC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| URI | UNITED RENTALS INC | 22.19 | 61.00B | ||
| FAST | FASTENAL CO | 45.59 | 54.41B | ||
| GWW | WW GRAINGER INC | 25.34 | 47.77B | ||
| FERG | FERGUSON ENTERPRISES INC | 22.9 | 44.94B | ||
| AER | AERCAP HOLDINGS NV | 9.88 | 21.06B | ||
| FTAI | FTAI AVIATION LTD | 42.76 | 17.72B | ||
| WSO.B | WATSCO INC -CL B | 30.87 | 16.31B | ||
| WSO | WATSCO INC | 30.13 | 15.93B | ||
| QXO | QXO INC | 132.19 | 14.25B | ||
| WCC | WESCO INTERNATIONAL INC | 17.49 | 10.50B | ||
| AIT | APPLIED INDUSTRIAL TECH INC | 25.83 | 9.87B | ||
| CNM | CORE & MAIN INC-CLASS A | 19.5 | 9.78B |
Related stock screener links
About BGLC
Company Profile
BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2020-03-11. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Company Info
BIONEXUS GENE LAB CORP
10-2 Tower B, Vertical Business Suite, 8 Jalan Kerinchi
KUALA LUMPUR WILAYAH PERSEKUTUAN MY
Employees: 9
Phone: 13072416898
BIONEXUS GENE LAB CORP / BGLC FAQ
What is the stock price of BIONEXUS GENE LAB CORP today?
The current stock price of BGLC is 5.77 USD. The price increased by 10.54% in the last trading session.
What is the ticker symbol for BIONEXUS GENE LAB CORP stock?
The exchange symbol of BIONEXUS GENE LAB CORP is BGLC and it is listed on the Nasdaq exchange.
On which exchange is BGLC stock listed?
BGLC stock is listed on the Nasdaq exchange.
What is BIONEXUS GENE LAB CORP worth?
BIONEXUS GENE LAB CORP (BGLC) has a market capitalization of 10.39M USD. This makes BGLC a Nano Cap stock.
How many employees does BIONEXUS GENE LAB CORP have?
BIONEXUS GENE LAB CORP (BGLC) currently has 9 employees.
What are the support and resistance levels for BIONEXUS GENE LAB CORP (BGLC) stock?
BIONEXUS GENE LAB CORP (BGLC) has a support level at 5.05 and a resistance level at 5.69. Check the full technical report for a detailed analysis of BGLC support and resistance levels.
Should I buy BIONEXUS GENE LAB CORP (BGLC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BGLC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BGLC, evaluating the profitability, health, valuation and growth aspects
- BIONEXUS GENE LAB CORP (BGLC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIONEXUS GENE LAB CORP (BGLC) Sales and EPS estimates to see what analysts future expectations are.
- BIONEXUS GENE LAB CORP (BGLC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIONEXUS GENE LAB CORP (BGLC) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIONEXUS GENE LAB CORP (BGLC) Stock Chart to make your own analysis
- BIONEXUS GENE LAB CORP (BGLC) Latest news and press-releases to stay up to date.
Does BIONEXUS GENE LAB CORP (BGLC) stock pay dividends?
BGLC does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIONEXUS GENE LAB CORP (BGLC)?
BIONEXUS GENE LAB CORP (BGLC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.18).
What is the Short Interest ratio of BIONEXUS GENE LAB CORP (BGLC) stock?
The outstanding short interest for BIONEXUS GENE LAB CORP (BGLC) is 5.47% of its float. Check the ownership tab for more information on the BGLC short interest.
BGLC Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to BGLC. When comparing the yearly performance of all stocks, BGLC is one of the better performing stocks in the market, outperforming 92.29% of all stocks.
BGLC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BGLC. While BGLC has a great health rating, there are worries on its profitability.
BGLC Financial Highlights
Over the last trailing twelve months BGLC reported a non-GAAP Earnings per Share(EPS) of -1.18. The EPS increased by 15.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.32% | ||
| ROE | -19.21% | ||
| Debt/Equity | 0 |